Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sonia Rebeles

Gynecology Fresno, CA Medical Doctor

NPI 1881891026 CMS profile 358474

2210 E Illinois Ave Ste 408, Fresno, CA 93701

Open in the dashboard

General payments

$15,990

76 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sonia Rebeles of Fresno, CA is reported in the CMS Open Payments database as having received $15,990 across 76 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $446 4
2024 General $11,151 13
2021 General $237 10
2020 General $312 10
2019 General $3,844 39

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sonia Rebeles
  • Gynecology median
  • Middle half of Gynecology
  • National median

In program year 2025, general payments to Sonia Rebeles were reported at $446. Among 1,279 Gynecology profiles paid that year, the median was $162 and the middle half received between $56 and $501.

Show as a table
Year Sonia Rebeles Gynecology median Middle half National median
2019 $3,844 $199 $66–$472 $163
2020 $312 $114 $42–$287 $114
2021 $237 $141 $42–$430 $132
2022 $0 $173 $52–$532 $149
2023 $0 $170 $57–$501 $160
2024 $11,151 $157 $50–$424 $164
2025 $446 $162 $56–$501 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Exeltis, USA Inc. $9,118 4 payments
  2. Intuitive Surgical, Inc. $5,225 17 payments
  3. Coloplast Corp $882 11 payments
  4. AbbVie, Inc. $272 13 payments
  5. Allergan Inc. $174 15 payments
  6. Covidien LP $45 1 payment
  7. Meditrina $42 2 payments
  8. TherapeuticsMD, Inc. $39 2 payments
  9. Bayer HealthCare Pharmaceuticals Inc. $32 2 payments
  10. Boston Scientific Corporation $30 1 payment
  11. Other $132 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $7,125 1 payment
  2. Travel and Lodging $4,331 15 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,875 1 payment
  4. Food and Beverage $1,622 54 payments
  5. Education $1,037 5 payments
Products named General payments · program years 2019–2025
  1. SLYND $9,118 4 payments
  2. Da Vinci Surgical System $4,225 16 payments
  3. DAVINCI XI $1,000 1 payment
  4. ALTIS Female Incontinence $805 5 payments
  5. LO LOESTRIN FE $341 23 payments
  6. Altis Women's Health $51 1 payment
  7. Endo GIA $45 1 payment
  8. LILETTA $40 2 payments
  9. Orilissa $35 2 payments
  10. Kyleena $32 2 payments
  11. Other $292 19 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

118

Median for Obstetrics & Gynecology: 65

Drug cost

$11,299

Median for Obstetrics & Gynecology: $3,585

Branded share of claims

39.8%

Median for Obstetrics & Gynecology: 25.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Osphena Ospemifene Brand 21 $6,418
Estradiol Generic 48 $2,546
Solifenacin Succinate Generic 11 $1,020
Estradiol (Twice Weekly) Estradiol Brand 11 $706
Progesterone Progesterone, Micronized Brand 15 $588
Triamcinolone Acetonide Generic 12 $21

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 24,311 Part D prescribers listed as Obstetrics & Gynecology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 22 billing codes

Paid by Medicare

$18,606

Medicare's payments for the services billed

Medicare patients

90

Average age 71

Services billed

266

90 women, 0 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 60%
Arthritis 46%
Osteoporosis 33%
Depression 23%
Diabetes 21%
Cancer 17%
Ischemic heart disease 16%
Chronic kidney disease 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
SLYND
  • Exeltis, USA Inc. $9,118
$9,118 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

76 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gynecology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record